Astrophel Pharmaceuticals Private Limited, a active private limited company, was established on 07 September 2013 in Mumbai, Maharashtra, India. Engaging in pharmaceutical retailers & distributors within the trade sector, it holds CIN: U74999MH2013PTC248004. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹1.65 M and a paid-up capital of ₹1.50 M.
It upholds a compliant status. Its leadership includes Rajesh Vijpar Shah (Director), Pradeep Tukaram More (Director). Past directors included Rashmikant Vijpar Shah, Bhavesh Sunilraj Sharma, Rohit Dilip Sadre. It holds ₹9.00 M open charges and no settled loans. Its latest AGM occurred on 30 September 2018, with the balance sheet filed on 31 March 2018. It is based at Row House No.4,Soyuz Complex, V.N. Purav Marg, Trombay,, Mumbai, Maharashtra, 400008.
U74999MH2013PTC248004
248004
07 September 2013
₹1.65 M
₹1.50 M
Roc Mumbai
Unlisted
Active
Explore comprehensive insights into Astrophel Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Rajesh Vijpar Shah | Director | 07 Sep 2013 | Current |
| Pradeep Tukaram More | Director | 07 Sep 2013 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 02 Apr 2019 | Past |
| Pramod Abcsdd | Director | 26 Aug 2015 | Past |
| Pramod Abcsdd | Director | 31 Mar 2019 | Past |
| Pramod Abcsdd | Director | 02 Apr 2019 | Past |
| Pramod Abcsdd | Director | 02 Apr 2019 | Past |
| Pramod Abcsdd | Director | 31 Mar 2019 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Astrophel Pharmaceuticals Private Limited, for the financial year ended 2018, experienced significant growth in revenue, with a 24.04% increase. The company also saw a slight improvement in profitability, with a 2.25% increase in profit. The company's net worth observed a substantial decline by a decrease of 17.51%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2018, Astrophel Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹9,000,000.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 11 Feb 2015 | Abhydaya Co-Operative Bank Limited | ₹4.00 M | Open |
| 08 Oct 2014 | Abhyudaya Co-Operative Bank Limited | ₹5.00 M | Open |
Explore comprehensive loan charge details -
Astrophel Pharmaceuticals has a workforce of 0 employees as of Apr 09, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Astrophel Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Astrophel Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Astrophel Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2018 as per latest MCA records. was recorded as a recent event.
Progress on Astrophel Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2018 with Roc Mumbai. was documented.
A charge with Abhyudaya Co-Operative Bank Limited of Rs. 5.00 M registered on 08 Oct 2014 with Charge ID 10526775 was modified on 07 Sep 2016. was recorded as a recent event.
The activity A charge with Abhydaya Co-Operative Bank Limited amounted to Rs. 4.00 M with Charge ID 10550133 was registered on 11 Feb 2015. was completed.
A charge with Abhyudaya Co-Operative Bank Limited amounted to Rs. 5.00 M with Charge ID 10526775 was registered on 08 Oct 2014. was recorded as a recent event.
Rajesh Vijpar Shah was appointed as a Director was appointed as a Director on 07 Sep 2013 & has been associated with this company since 12 years 4 months . was recorded as a recent event.
The CIN of Astrophel Pharmaceuticals Private Limited is U74999MH2013PTC248004.
Astrophel Pharmaceuticals Private Limited is headquartered at Row House No.4,Soyuz Complex, V.N. Purav Marg, Trombay,, Mumbai, Maharashtra, 400008.
Astrophel Pharmaceuticals Private Limited was incorporated on 07 September 2013.
The current directors of Astrophel Pharmaceuticals Private Limited are
The primary industry of Astrophel Pharmaceuticals Private Limited is Trade.
Astrophel Pharmaceuticals Private Limited is unlisted.
The authorized capital of Astrophel Pharmaceuticals Private Limited is ₹1.65 M, and the paid-up capital is ₹1.50 M.
The compliance status of Astrophel Pharmaceuticals Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX